David Carcedo
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
A Decade of Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Breast Cancer in Spain: A Comprehensive Real-World Data Analysis (2013-2023).
Journal: Clinical breast cancer
Published: January 29, 2026
A Response to: Letter to the Editor Regarding "Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician's Choice of Treatment in Spain".
Journal: Oncology and therapy
Published: December 02, 2025
Economic burden of recurrence in patients with hepatocellular carcinoma after curative-intent treatment in Spain.
Journal: Health economics review
Published: August 12, 2025
Comparison of the efficiency of digital pathology with the conventional methodology for the diagnosis of biopsies in an anatomical pathology laboratory in Spain.
Journal: Journal of pathology informatics
Published: January 03, 2025
Cost-effectiveness of a machine learning risk prediction model (LungFlag) in the selection of high-risk individuals for non-small cell lung cancer screening in Spain.
Journal: Journal of medical economics
Published: December 19, 2024
Detection of genomic alterations in liquid biopsies from patients with non-small cell lung cancer using FoundationOne Liquid CDx: a cost-effectiveness analysis.
Journal: Journal of medical economics
Published: October 10, 2024
Actionable mutational profiling in solid tumors using hybrid-capture-based next-generation sequencing in a real-world setting in Spain.
Journal: Cancer medicine
Published: August 14, 2023
Cost-effectiveness of adjuvant atezolizumab versus best supportive care in the treatment of patients with resectable early-stage non-small cell lung cancer and overexpression of PD-L1.
Journal: Journal of medical economics
Published: March 08, 2023
Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non-Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers.
Journal: JCO precision oncology
Published: March 02, 2023
Last Updated: 09/26/2026